Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Scientific News Boston Scientific S Swot Analysis Medtech Giant S Stock Poised For Growth

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific S Swot Analysis Medtech Giant S Stock Poised For Growth is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Boston Scientific S Swot Analysis Medtech Giant S Stock Poised For Growth | RobinsPost News & Noticias

Boston Scientific Shares Surge on Exceptional Quarterly Performance


The medical technology sector is witnessing remarkable momentum as Boston Scientific delivers a stunning third-quarter report for 2025. While the financial r ... Read More

Boston Scientific Up 7% in a Month: How Should You Play the Stock?


Shares of Boston Scientific BSX have climbed 7% over the past 30 days, extending their positive year-to-date momentum. The stock’s performance has outpaced its industry’s 0.9% gains, the broader ... Read More

Boston Scientific (BSX) Stock Is Up, What You Need To Know


Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.4% in the morning session after the company reported strong third-quarter results that topped Wall Street's forecasts and raised ... Read More

Boston Scientific rises as cardiology sales drive Q3 beat, guidance boost


Boston Scientific (NYSE:BSX) traded higher on Wednesday after the MedTech giant exceeded Street forecasts with its Q3 2025 results and boosted its full-year outlook following better-than-expected ... Read More

Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story?


Boston Scientific Corp. (NYSE: BSX) is one of the best stocks to buy according to Citadel LLC. On October 22, Josh Jennings, an analyst at TD Cowen, reiterated his $115 price target and Buy rating on ... Read More

Analyst Visit Confirms Growth Potential for Boston Scientific Corporation (BSX), Buy Rating Retained


Boston Scientific Corporation (NYSE:BSX) ranks among the best medical device stocks to invest in. Following an analyst visit to Boston Scientific Corporation (NYSE:BSX)’s headquarters, TD Cowen ... Read More

Boston Scientific: Not In The Most Resolute State As It Approaches Q3 Earnings


Boston Scientific, which was faring relatively well over the first 8 months of the year, appears to have lost its footing of late and is now trading below all its key moving averages. The upcoming Q3 ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus